Improving Long-Term Outcomes in Patients With Schizophrenia: What Is the Evidence for Long-Acting Injectable Antipsychotics?

LOGIN

REGISTER

SUBSCRIBE


Forgot your login? GET HELP

Do you consider long-acting injectable (LAI) antipsychotics when selecting among treatments for schizophrenia? Take part in this CME activity to review the evidence for LAIs vs oral medications and to learn which patients may benefit most from this treatment option. Plus, discover the pharmacokinetic properties of LAIs and barriers to their use.

See the entire activity.

J Clin Psychiatry 2017;78(9):e1431

https://doi.org/10.4088/JCP.ot16046tx1cj